Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Bionordika AS
AS
Active
Org 942855869
Gladengveien 3B, 0661
Oslo
Wholesale of chemical products
·
NACE 4685
Est. 1986 · 39 years old
11 employees
www.bionordikabergman.no
Monitor
Share
Norway
/
Companies
/
Wholesale of chemical products
/
Bionordika AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
85M
64M
42M
21M
0M
2021: 68M
68M
2021
2022: 54M (-21% vs 2021)
54M
-21%
2022
2023: 45M (-17% vs 2022)
45M
-17%
2023
2024: 43M (-4% vs 2023)
43M
-4%
2024
2025: 50M (+16% vs 2024)
50M
+16%
2025
EBITDA
NOK millions
25M
19M
12M
6M
0M
2021: 20M
20M
2021
2022: 11M (-45% vs 2021)
11M
-45%
2022
2023: 4M (-64% vs 2022)
4M
-64%
2023
2024: 2M (-50% vs 2023)
2M
-50%
2024
2025: 6M (+200% vs 2024)
6M
+200%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
50 339
43 483
44 901
54 258
68 053
Staff expenses
−12 431
−12 652
−11 360
−11 296
−10 802
EBITDA
6 085
2 148
3 517
10 926
19 792
Depreciation & amort.
−167
−174
−163
−172
−171
EBIT
5 918
1 974
3 354
10 754
19 620
Net financials
596
380
210
297
−115
Profit before tax
6 513
2 354
3 564
11 051
19 505
Tax
1 447
534
803
2 446
4 309
Net profit
5 067
1 820
2 762
8 605
15 197
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
21 542
20 322
18 240
26 660
36 402
Equity
7 254
7 187
7 367
7 605
7 500
Long-term debt
0
0
0
193
0
Short-term debt
14 169
11 904
10 752
18 862
28 901
Total debt
14 169
11 904
10 752
19 054
28 901
Financial ratios
5-year trend
EBITDA margin
12,1 %
This company
15,8 %
Market median
This company
Market median
23% below market
2021
2025
Equity ratio
33,7 %
This company
38,2 %
Market median
This company
Market median
12% below market
2021
2025
Return on equity
69,9 %
This company
18,4 %
Market median
This company
Market median
280% above market
2021
2025
Net profit margin
10,1 %
This company
8,1 %
Market median
This company
Market median
25% above market
2021
2025
Asset turnover
2,34×
This company
1,12×
Market median
This company
Market median
109% above market
2021
2025
Debt / equity
1,97×
This company
0,62×
Market median
This company
Market median
218% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Bionordika AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
